Signal
in the noise.
The science that defines the next decade is already alive in a lab somewhere, quiet, unfunded, easy to miss. We hear it first.
Breakthroughs don’t announce themselves. They surface as noise.
A result that holds. A patent no one has read. A clinician’s hunch. We are built to tell the signal from the noise, and to back it before it’s obvious.
Science with a clinical destination.
New modalities from academic discovery.
Intervention founded on clinical insight.
Making the invisible measurable.
Where compliance is the moat.
The first believers, before the signal is obvious to anyone else.
The large funds arrive once the science is de-risked and the round is loud. We arrive while it’s still a rumour inside the university.
Three moves.
Listen
We source at the boundary of the lab, labs, tech transfer offices, clinicians, before the science is shopped.
Back
We write the first institutional check, on conviction, at the moment most capital won’t.
Build
We take a board or advisory seat and help carry a finding to a fundable company.
Less noise. More signal.
Occasional notes on the earliest moments in healthcare, and the founders building through them.